These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

331 related items for PubMed ID: 4397414

  • 1. The potential use of xylitol in glucose-6-phosphate dehydrogenase deficiency anemia.
    Wang YM, Patterson JH, Van Eys J.
    J Clin Invest; 1971 Jul; 50(7):1421-8. PubMed ID: 4397414
    [Abstract] [Full Text] [Related]

  • 2. Defenses against oxidation in human erythrocytes: role of glutathione reductase in the activation of glucose decarboxylation by hemolytic drugs.
    Hohl RJ, Kennedy EJ, Frischer H.
    J Lab Clin Med; 1991 Apr; 117(4):325-31. PubMed ID: 1901343
    [Abstract] [Full Text] [Related]

  • 3. The use of primaquine in malaria infected patients with red cell glucose-6-phosphate dehydrogenase (G6PD) deficiency in Myanmar.
    Myat-Phone-Kyaw, Myint-Oo, Aung-Naing, Aye-Lwin-Htwe.
    Southeast Asian J Trop Med Public Health; 1994 Dec; 25(4):710-3. PubMed ID: 7667719
    [Abstract] [Full Text] [Related]

  • 4. Xylitol mediated amelioration of acetylphenylhydrazine-induced hemolysis in rabbits.
    Ukab WA, Sato J, Wang YM, van Eys J.
    Metabolism; 1981 Nov; 30(11):1053-9. PubMed ID: 7289879
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Band 3 tyr-phosphorylation in normal and glucose-6-phospate dehydrogenase-deficient human erythrocytes.
    Bordin L, Zen F, Ion-Popa F, Barbetta M, Baggio B, Clari G.
    Mol Membr Biol; 2005 Nov; 22(5):411-20. PubMed ID: 16308275
    [Abstract] [Full Text] [Related]

  • 9. Characterization of erythrocytic glucose-6-phosphate dehydrogenase in a mouse strain with reduced G6PD activity.
    Neifer S, Jung A, Bienzle U.
    Biomed Biochim Acta; 1991 Nov; 50(3):233-8. PubMed ID: 1953691
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Understanding the mechanisms for metabolism-linked hemolytic toxicity of primaquine against glucose 6-phosphate dehydrogenase deficient human erythrocytes: evaluation of eryptotic pathway.
    Ganesan S, Chaurasiya ND, Sahu R, Walker LA, Tekwani BL.
    Toxicology; 2012 Mar 29; 294(1):54-60. PubMed ID: 22330256
    [Abstract] [Full Text] [Related]

  • 14. Dapsone-induced hemolytic anemia: role of glucose-6-phosphate dehydrogenase in the hemolytic response of rat erythrocytes to N-hydroxydapsone.
    Grossman S, Budinsky R, Jollow D.
    J Pharmacol Exp Ther; 1995 May 29; 273(2):870-7. PubMed ID: 7752092
    [Abstract] [Full Text] [Related]

  • 15. [Detection of a new anomalous variant of glucose-6-phosphate dehydrogenase in human erythrocytes].
    Batishchev AI, Cherniak NB, Tokarev IuN.
    Biull Eksp Biol Med; 1977 Dec 29; 84(12):728-31. PubMed ID: 23188
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Henna: a potential cause of oxidative hemolysis and neonatal hyperbilirubinemia.
    Zinkham WH, Oski FA.
    Pediatrics; 1996 May 29; 97(5):707-9. PubMed ID: 8628611
    [Abstract] [Full Text] [Related]

  • 18. [Formate incubation of red blood cells from glucose-6-phosphate-dehydrogenase-deficient patients].
    Grieger M, Schippel W, Siems W, Leppin K.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1983 May 29; 110(5):704-15. PubMed ID: 6198254
    [Abstract] [Full Text] [Related]

  • 19. [Impaired glutathione metabolism in hemolytic anemia].
    Kondo T.
    Rinsho Byori; 1990 Apr 29; 38(4):355-9. PubMed ID: 2195189
    [Abstract] [Full Text] [Related]

  • 20. Primaquine-induced hemolytic anemia: susceptibility of normal versus glutathione-depleted rat erythrocytes to 5-hydroxyprimaquine.
    Bowman ZS, Oatis JE, Whelan JL, Jollow DJ, McMillan DC.
    J Pharmacol Exp Ther; 2004 Apr 29; 309(1):79-85. PubMed ID: 14724225
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.